查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1308654

2030 年面部注射剂市场预测 - 按产品类型、应用、最终用户和地区划分的全球分析

Facial Injectables Market Forecasts to 2030 - Global Analysis By Product Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球面部注射市场规模将达到 59.4 亿美元，预计在预测期内復合年增长率为 11.6%，到 2030 年将达到 128 亿美元。

真皮填充剂，也称为面部注射，是一种使面部恢復活力的化妆品。为了改善美观，这些面部注射产品通常用于治疗皱纹和其他早期衰老迹象。它还有助于人口老龄化和更好的面部注射剂（例如人造氢氧化钙填充剂）的开发。

据美国整形外科医生协会 (ASPS) 统计，2019 年美国约 25.0% 的整容手术是在医院进行的。

市场动态：

促进者

对微创美容手术的需求不断增长

全球面部注射市场预计将在预测期内推动增长，由于对最短恢復时间、减轻疼痛和降低手术相关风险的渴望，将推动对非侵入性整容手术的需求迅速增长。对于那些想在不进行手术的情况下改善外表的人来说，面部注射是一种方便、非侵入性的选择。社交媒体和因人们渴望向世界展示自己最好的一面而发展起来的自拍文化也推动了这一趋势。

抑製剂

非常贵

预计全球面部注射剂市场在预测期内的增长将受到阻碍。面部注射的高昂费用可能成为患者接受治疗的重大障碍，特别是在发展中国家，那里的治疗对许多人来说往往很昂贵。此外，这些治疗方法的高价格可能会阻碍患者接受维持注射，从而导致公司的整体市场回报较低。为了解决这个问题，一些运营商正在寻找替代定价结构，例如统一费率计划。

机会：

对联合疗法的兴趣日益浓厚

预计全球面部注射剂市场将在预测期内推动增长。混合各种面部注射（包括填充剂和神经调节剂）的组合疗法越来越受欢迎。能够提供包含多种疗法的综合治疗方案的公司可能会从这一趋势中受益。例如，一些公司现在提供“液体整容”治疗，将注射与其他微创技术相结合，提供完整的面部年轻化解决方案。

威胁：

供应链中断

预计全球面部注射市场在预测期内将阻碍增长。例如，原材料和製造设备的短缺可能会导致面部注射市场的混乱。这些障碍可能导致产品开发和製造延迟、供应减少和消费价格上涨。为了应对这一威胁，市场上的公司必须实现供应链多元化，投资于库存管理系统，并与供应商保持牢固的联繫，以确保原材料的稳定供应。

COVID-19 的影响：

由于安全问题、金融不稳定、供应链中断和监管审查加强，COVID-19 大流行影响了面部注射剂市场，导致需求减少。为了适应这种情况，公司正在投资新技术、安全程序和产品开发。随着企业应对疫情的挑战，市场可能会保持活力和创新。随着世界努力应对这一流行病的挑战，面部注射市场可能会保持活力和创新。

在预测期内，真皮填充剂预计将成为最大的细分市场：

真皮填充剂预计将在预测期内占据最大份额。与外科手术相比，真皮填充剂因其效率高、价格实惠且并发症风险相对较低而广受欢迎。它们用于恢復体积和抚平皱纹。这种市场渗透是由具有不同配方和注射方法的各种真皮填充剂产品的可用性推动的。人口老龄化、对非手术整容手术的认识和接受度不断提高以及持续的产品创新都将促进这一增长。随着真皮填充剂需求的增加，面向市场的公司可能会投资研发来开发新的和改进的产品，这些产品可以提供更好的效果、更持久的效果和更少的副作用。

预计门诊手术中心部分在预测期内将呈现最高的复合年增长率：

预计门诊手术中心部分在预测期内将呈现最快的复合年增长率。您可以选择手术和非手术程序。影响该市场增长的因素包括对微创整容手术的需求不断增长、人们对面部注射益处的了解不断增加以及 ASC 的接受度不断提高。许多 ASC 还投资新技术、设备和员工培训，为患者提供安全有效的美容服务。

占比最大的地区

由于对非侵入性整容手术的高需求，预计北美区域市场在预测期内将占全球面部注射剂市场的最大份额，其中美国是北美最大的面部注射剂市场..由于人们对整容手术的认识和接受程度提高，以及各种面部注射产品的出现，该地区的市场不断增长。由于微创美容手术的接受度不断提高以及技术的持续发展，北美面部注射市场预计将在未来几年扩大。

复合年增长率最高的地区：

预计亚太地区在预测期内的复合年增长率最高。对非手术整容手术的需求不断增长、可支配收入增加以及人们对整容手术的认识和接受度不断提高，促进了该地区的增长。尖端、新颖的面部注射产品的出现以及提供这些服务的医疗机构和医疗专业人员数量的不断增加预计将支持该地区的增长。此外，由于泰国、韩国和印度等国家医疗旅游的增长趋势，亚太面部注射器市场预计将增长。

主要发展：

2022 年 8 月，Allergan Healthcare India在其Allergan Aesthetics美容业务部门推出了 Juvederm VOLUX，这是一种可注射植入物，旨在恢復和塑造面部体积。

2022 年 3 月，Galderma 在 AMWC 2022 上展示了其真皮填充剂、胶原蛋白生物刺激剂和液体神经调节剂产品组合的新临床数据和高患者满意度。在 2022 年美容与抗衰老医学世界大会上，Galderma 展示了有关其透明质酸真皮填充剂系列产品组合、首款液体神经调节剂和原创胶原蛋白生物刺激剂的一系列新科学数据。

2022 年 2 月，Amnir 推出四种新产品，扩大了其註射剂产品组合。地塞米松磷酸钠注射液USP 10mg/mL、氮胞甘100mg、卡前列米胺注射液USP 250mcg/mL、硫酸阿托品注射液USP 0.5mg/5mL 已收到美国食品和药物管理局的简短新药申请。地塞米松和阿扎胞甘目前均在 FDA 的短缺药物名单上，阿托品已获得 FDA 的竞争性仿製药治疗批准。

报告内容

  • 区域和国家层面的市场份额评估
  • 对新进入者的战略建议
  • 涵盖 2021、2022、2023、2026 和 2030 年的市场数据
  • 市场趋势（市场驱动因素/制约因素/机会/威胁/挑战/投资机会/建议）
  • 根据市场预测提出关键业务领域的战略建议
  • 竞争格局绘製主要流行趋势
  • 公司概况，包括详细战略、财务状况和近期发展
  • 映射最新技术进步的供应链趋势

免费定制服务：

订阅此报告的客户将获得以下免费定制选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要公司的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（注：通过可行性检查）
  • 竞争标桿
    • 根据产品组合、地域分布和战略联盟对主要参与者进行基准测试

目录

第一章内容提要

第二章前言

  • 概述
  • 利益相关者
  • 调查范围
  • 调查方法
    • 数据挖掘
    • 数据分析
    • 数据验证
    • 研究方法
  • 研究来源

第三章市场趋势分析

  • 促进者
  • 抑製剂
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5.全球面部注射剂市场，按产品类型

  • 皱纹鬆弛剂
    • A型肉毒桿菌毒素
  • 真皮填充剂
    • 胶原
    • 透明质酸
    • 羟基磷灰石钙
    • 聚乳酸
    • 聚甲基丙烯酸甲酯微球（PMMA）
    • 脂肪注射
  • 聚合物填料
  • 其他产品类型

6.全球面部注射剂市场（按应用）

  • 减少皱纹
  • 面部提升术
  • 美学
  • 疗法
  • 痤疮疤痕治疗
  • 脂肪营养不良的治疗
  • 面部线条矫正
  • 丰唇术
  • 其他用途

7. 全球面部注射剂市场（按最终用户）

  • 医院
  • 门诊手术中心
  • 皮肤科诊所
  • 化妆品中心
  • 皮肤病学调查
  • 美容诊所
  • 医疗水疗
  • 其他最终用户

8.全球面部注射剂市场（按地区）

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 意大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 新西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 卡塔尔
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十章公司简介

  • Allergan, Plc.
  • Alma Laser
  • Anika Therapeutics, Inc.
  • Antares Pharma
  • Bausch Health Companies In
  • BIOPLUS CO., LTD.
  • Bioxis Pharmaceuticals
  • Bloomage BioTechnology Corporation Limited
  • ColBar LifeScience Ltd.
  • Dickinson and Company
  • Galderma Pharma S.A.
  • Ipsen Pharma
  • Medytox, Inc.
  • Merz Pharma
  • Prollenium Medical Technologies Inc.
  • Revance Therapeutics, Inc.
  • Sinclair Pharma Plc
  • Solta Medical
  • Suneva Medical, Inc.
  • Syneron Candela
Product Code: SMRC23354

According to Stratistics MRC, the Global Facial Injectables Market is accounted for $5.94 billion in 2023 and is expected to reach $12.80 billion by 2030 growing at a CAGR of 11.6% during the forecast period. Dermal fillers, also referred to as facial injectable products, are cosmetics that rejuvenate the face. In order to improve aesthetic beauty, these facial injectable products are typically used to treat wrinkles and other early signs of aging. It is also aided in the number of elderly people and the development of superior facial injectables like artificial calcium hydroxylapatite fillers.

According to the American Society of Plastic Surgeons (ASPS), in 2019, an estimated 25.0% of cosmetic procedures were performed in hospitals in the United States.

Market Dynamics:

Driver:

Increasing demand for minimally invasive cosmetic procedures

The global Facial Injectables market expected to drive growth during the forecast period, due to the desire for minimal recovery time, less pain, and fewer risks associated with surgery, the demand for non-invasive cosmetic procedures is increasing quickly. People who want to enhance their appearance without having surgery have a convenient, non-invasive option with facial injectables. Social media and the selfie culture that has developed as a result of people's increasing desire to present their best selves to the world have also contributed to this trend.

Restraint:

Very expensive

The global Facial Injectables market expected to hinder growth during the forecast period. Particularly in developing nations, where the cost of treatment can be prohibitive for many people, the high cost of facial injectables can be a major barrier to patient uptake. Additionally, the high price of these treatments may deter patients from getting maintenance injections, resulting in lower overall market revenue for businesses. In an effort to resolve this problem, some businesses are looking into different pricing structures, like subscription-based plans, which might make facial injectables more affordable for a wider range of patients.

Opportunity:

Rising interest in combination therapies

The global Facial Injectables market expected to drive growth during the forecast period. Combination therapies, which mix various facial injectables, including fillers and neuromodulators, are gaining popularity. Businesses that can provide comprehensive treatment options that incorporate multiple therapies will probably be well-positioned to benefit from this trend. As an illustration, some businesses now provide "liquid facelift" treatments that combine injectables with other minimally invasive techniques to offer a complete facial rejuvenation solution.

Threat:

Disruptions in the supply chain

The global Facial Injectables market expected to hamper growth during the forecast period. A disruption in the facial injectables market could result from a lack of raw materials or manufacturing equipment, for example. These setbacks may result in slower product development and manufacturing, a smaller supply, and higher consumer prices. Companies in the market need to diversify their supply chains, make investments in inventory management systems, and keep strong ties with suppliers to guarantee a steady supply of raw materials to combat this threat.

COVID-19 Impact:

Due to safety concerns, financial uncertainty, disruption of supply chains, and increased regulatory scrutiny, the COVID-19 pandemic has had an impact on the facial injectables market, resulting in decreased demand. To adapt, businesses have made investments in new technologies, safety procedures, and product development. As businesses navigate the challenges of the pandemic, the market is likely to remain dynamic and innovative. The facial injectables market is likely to stay dynamic and innovative as the world struggles to deal with the pandemic's challenges because businesses are working hard to meet patients' changing needs in an environment that is changing quickly.

The dermal fillers segment is expected to be the largest during the forecast period:

The dermal fillers segment is expected to be the largest share during the forecast period Dermal fillers are popular for their efficiency, affordability, and comparably low risk of complications when compared to surgical procedures. They are used to restore volume and smooth out wrinkles. The proliferation of this market has been aided by the accessibility of a wide variety of dermal filler products with various formulations and injection methods. The aging population, rising awareness and acceptance of non-surgical cosmetic procedures, and ongoing product innovation will all contribute to this growth. Companies in the market are likely to invest in R&D to develop new and improved products that offer better results, longer-lasting effects, and fewer side effects as the demand for dermal fillers rises.

The ambulatory surgery centers segment is expected to have the highest CAGR during the forecast period:

The ambulatory surgery centers segment is anticipated to witness the fastest CAGR growth during the forecast period Patients looking to enhance their appearance can choose from a variety of surgical and non-surgical procedures at ambulatory surgery centers (ASCs), including facial injectables. Some of the factors influencing the growth of this market include the rising demand for minimally invasive cosmetic procedures, the growing knowledge of the advantages of facial injectables, and the increasing acceptance of ASCs. In order to offer their patients safe and effective cosmetic services, many ASCs have also made investments in new technologies, equipment, and staff training.

Region with largest share:

The North America region market is estimated to witness a largest share of the global Facial Injectables market during the forecast period, due to the high demand for non-invasive aesthetic procedures, the United States is North America's largest market for facial injectables. The market in this region has expanded as a result of rising awareness and acceptance of cosmetic procedures as well as the availability of a wide variety of facial injectable products. The market for facial injectables in North America is anticipated to expand over the ensuing years, helped along by the rising acceptance of minimally invasive cosmetic procedures and ongoing developments in technology.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period. The demand for non-surgical cosmetic procedures is rising, there is more disposable income available, and people are becoming more aware of and accepting of aesthetic procedures, all of which contribute to this region's growth. The availability of cutting-edge and novel facial injectable products, as well as the rising number of healthcare facilities and medical professionals providing these services, are anticipated to support growth in this area. Additionally, the market for facial injectables in Asia Pacific is anticipated to expand as a result of the expanding trend of medical tourism in nations like Thailand, South Korea, and India.

Key players in the market

Some of the key players in Facial Injectables market include Allergan, Plc., Alma Laser , Anika Therapeutics, Inc., Antares Pharma , Bausch Health Companies In, BIOPLUS CO., LTD., Bioxis Pharmaceuticals, Bloomage BioTechnology Corporation Limited , ColBar LifeScience Ltd., Dickinson and Company, Galderma Pharma S.A., Ipsen Pharma, Medytox, Inc., Merz Pharma, Prollenium Medical Technologies Inc., Revance Therapeutics, Inc., Sinclair Pharma Plc, Solta Medical, Suneva Medical, Inc. and Syneron Candela.

Key Developments:

In August 2022, Allergan Healthcare India launched Juvederm VOLUX, an injectable implant intended to restore and create the volume of the face, under its Business Unit of Allergan Aesthetics.

In March 2022, Galderma presented its new clinical data and high patient satisfaction across its portfolio of dermal fillers, collagen bio stimulators, and liquid neuromodulators at AMWC 2022. Galderma presented a range of new scientific data on its portfolio on its hyaluronic acid dermal filler range, its first liquid neuromodulator, and its original collagen biostimulator at the Aesthetic & Anti-Aging Medicine World Congress 2022.

In February 2022, Amneal expanded its injectables portfolio with 4 new products. Dexamethasone sodium phosphate injection, USP 10 mg/mL, azacitidine 100 mg, carboprost tromethamine injection, USP 250 mcg/mL, and atropine sulfate injection, USP 0.5 mg/5 mL, have received Abbreviated New Drug Application approval from the US Food and Drug Administration. Dexamethasone and azacitidine are both currently on the FDA drug shortage list, and Atroprine was granted Competitive Generic Therapy status by the FDA.

Product Types Covered:

  • Wrinkle Relaxers
  • Dermal Fillers
  • Polymer Fillers
  • Other Product Types

Applications Covered:

  • Wrinkle Reduction
  • Facelift
  • Aesthetics
  • Therapeutics
  • Acne Scar Treatment
  • Lipoatrophy Treatment
  • Facial Line Correction
  • Lip Augmentation
  • Other Applications

End Users Covered:

  • Hospitals
  • Ambulatory Surgery Centers
  • Dermatology Clinics
  • Cosmetic Centers
  • Dermatology Research Institutes
  • Beauty Clinics
  • Medical Spas
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Facial Injectables Market, By Product Type

  • 5.1 Introduction
  • 5.2 Wrinkle Relaxers
    • 5.2.1 Botulinum Toxin Type A
  • 5.3 Dermal Fillers
    • 5.3.1 Collagen
    • 5.3.2 Hyaluronic Acid
    • 5.3.3 Calcium Hydroxylapatite
    • 5.3.4 Polylactic Acid
    • 5.3.5 Polymethyl-methacrylate Microspheres (PMMA)
    • 5.3.6 Fat Injection
  • 5.4 Polymer Fillers
  • 5.5 Other Product Types

6 Global Facial Injectables Market, By Application

  • 6.1 Introduction
  • 6.2 Wrinkle Reduction
  • 6.3 Facelift
  • 6.4 Aesthetics
  • 6.5 Therapeutics
  • 6.6 Acne Scar Treatment
  • 6.7 Lipoatrophy Treatment
  • 6.8 Facial Line Correction
  • 6.9 Lip Augmentation
  • 6.10 Other Applications

7 Global Facial Injectables Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgery Centers
  • 7.4 Dermatology Clinics
  • 7.5 Cosmetic Centers
  • 7.6 Dermatology Research Institutes
  • 7.7 Beauty Clinics
  • 7.8 Medical Spas
  • 7.9 Other End Users

8 Global Facial Injectables Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Allergan, Plc.
  • 10.2 Alma Laser
  • 10.3 Anika Therapeutics, Inc.
  • 10.4 Antares Pharma
  • 10.5 Bausch Health Companies In
  • 10.6 BIOPLUS CO., LTD.
  • 10.7 Bioxis Pharmaceuticals
  • 10.8 Bloomage BioTechnology Corporation Limited
  • 10.9 ColBar LifeScience Ltd.
  • 10.10 Dickinson and Company
  • 10.11 Galderma Pharma S.A.
  • 10.12 Ipsen Pharma
  • 10.13 Medytox, Inc.
  • 10.14 Merz Pharma
  • 10.15 Prollenium Medical Technologies Inc.
  • 10.16 Revance Therapeutics, Inc.
  • 10.17 Sinclair Pharma Plc
  • 10.18 Solta Medical
  • 10.19 Suneva Medical, Inc.
  • 10.20 Syneron Candela

List of Tables

  • Table 1 Global Facial Injectables Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Facial Injectables Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Facial Injectables Market Outlook, By Wrinkle Relaxers (2021-2030) ($MN)
  • Table 4 Global Facial Injectables Market Outlook, By Botulinum Toxin Type A (2021-2030) ($MN)
  • Table 5 Global Facial Injectables Market Outlook, By Dermal Fillers (2021-2030) ($MN)
  • Table 6 Global Facial Injectables Market Outlook, By Collagen (2021-2030) ($MN)
  • Table 7 Global Facial Injectables Market Outlook, By Hyaluronic Acid (2021-2030) ($MN)
  • Table 8 Global Facial Injectables Market Outlook, By Calcium Hydroxylapatite (2021-2030) ($MN)
  • Table 9 Global Facial Injectables Market Outlook, By Polylactic Acid (2021-2030) ($MN)
  • Table 10 Global Facial Injectables Market Outlook, By Polymethyl-methacrylate Microspheres (PMMA) (2021-2030) ($MN)
  • Table 11 Global Facial Injectables Market Outlook, By Fat Injection (2021-2030) ($MN)
  • Table 12 Global Facial Injectables Market Outlook, By Polymer Fillers (2021-2030) ($MN)
  • Table 13 Global Facial Injectables Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 14 Global Facial Injectables Market Outlook, By Application (2021-2030) ($MN)
  • Table 15 Global Facial Injectables Market Outlook, By Wrinkle Reduction (2021-2030) ($MN)
  • Table 16 Global Facial Injectables Market Outlook, By Facelift (2021-2030) ($MN)
  • Table 17 Global Facial Injectables Market Outlook, By Aesthetics (2021-2030) ($MN)
  • Table 18 Global Facial Injectables Market Outlook, By Therapeutics (2021-2030) ($MN)
  • Table 19 Global Facial Injectables Market Outlook, By Acne Scar Treatment (2021-2030) ($MN)
  • Table 20 Global Facial Injectables Market Outlook, By Lipoatrophy Treatment (2021-2030) ($MN)
  • Table 21 Global Facial Injectables Market Outlook, By Facial Line Correction (2021-2030) ($MN)
  • Table 22 Global Facial Injectables Market Outlook, By Lip Augmentation (2021-2030) ($MN)
  • Table 23 Global Facial Injectables Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 24 Global Facial Injectables Market Outlook, By End User (2021-2030) ($MN)
  • Table 25 Global Facial Injectables Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 26 Global Facial Injectables Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
  • Table 27 Global Facial Injectables Market Outlook, By Dermatology Clinics (2021-2030) ($MN)
  • Table 28 Global Facial Injectables Market Outlook, By Cosmetic Centers (2021-2030) ($MN)
  • Table 29 Global Facial Injectables Market Outlook, By Dermatology Research Institutes (2021-2030) ($MN)
  • Table 30 Global Facial Injectables Market Outlook, By Beauty Clinics (2021-2030) ($MN)
  • Table 31 Global Facial Injectables Market Outlook, By Medical Spas (2021-2030) ($MN)
  • Table 32 Global Facial Injectables Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.